1,498 Shares in The Allstate Co. (NYSE:ALL) Acquired by Commerzbank Aktiengesellschaft FI

Commerzbank Aktiengesellschaft FI acquired a new stake in The Allstate Co. (NYSE:ALL) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 1,498 shares of the insurance provider’s stock, valued at approximately $285,000.

A number of other institutional investors have also recently modified their holdings of the stock. Northwest Investment Counselors LLC acquired a new position in Allstate in the third quarter valued at about $28,000. Versant Capital Management Inc increased its holdings in Allstate by 70.9% in the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after buying an additional 78 shares during the period. Family Firm Inc. acquired a new position in shares of Allstate in the 2nd quarter valued at approximately $38,000. MCF Advisors LLC lifted its holdings in shares of Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after acquiring an additional 84 shares during the period. Finally, Sunbelt Securities Inc. boosted its position in shares of Allstate by 38.5% during the 1st quarter. Sunbelt Securities Inc. now owns 363 shares of the insurance provider’s stock worth $63,000 after acquiring an additional 101 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the sale, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, EVP Robert Toohey sold 16,682 shares of the company’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $180.17, for a total value of $3,005,595.94. Following the completion of the sale, the executive vice president now owns 4,873 shares of the company’s stock, valued at approximately $877,968.41. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 192,530 shares of company stock valued at $34,967,665 in the last quarter. Corporate insiders own 1.80% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on ALL shares. Raymond James boosted their price objective on shares of Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research report on Friday, October 4th. Evercore ISI upped their price objective on Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 9th. BMO Capital Markets raised their price objective on Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Barclays assumed coverage on Allstate in a research note on Wednesday, September 4th. They set an “underweight” rating and a $175.00 target price for the company. Finally, Bank of America raised their price target on shares of Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Allstate has an average rating of “Moderate Buy” and a consensus target price of $206.44.

Allstate Stock Performance

Allstate stock opened at $192.00 on Friday. The firm’s 50 day simple moving average is $187.73 and its 200 day simple moving average is $174.23. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $50.67 billion, a PE ratio of 42.38, a price-to-earnings-growth ratio of 1.74 and a beta of 0.48. The Allstate Co. has a 1-year low of $122.53 and a 1-year high of $198.79.

Allstate (NYSE:ALL) last posted its earnings results on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.33 by $1.28. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The business had revenue of $15.71 billion for the quarter, compared to analyst estimates of $14.04 billion. During the same quarter in the prior year, the firm posted ($4.42) EPS. Allstate’s revenue was up 12.4% on a year-over-year basis. As a group, analysts expect that The Allstate Co. will post 15.19 earnings per share for the current fiscal year.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.